title: Tricuspid valve incompetence following implantation of ventricular leads.
abstract: Most cardiovascular implantable electronic devices (CIEDs) require a ventricular lead to be placed across the tricuspid valve. Tricuspid regurgitation (TR) is an understudied clinical complication of right ventricular lead implantation and its clinical significance is unknown. We review the incidence, predictors, and current management of TR as a complication of ventricular lead implantation. Emerging technologies, including leadless pacing devices and subcutaneous systems, offer the benefit of little or none tricuspid valve disruption.
authors.affiliation: Division of Cardiology, Department of Medicine, Penn State College of Medicine, Penn State Hershey Heart and Vascular Institute, Penn State University, 500 University Drive. Mail Code H047, PO BOX 850, Hershey, PA, 17033, USA, gbaquero@hmc.psu.edu.
authors.forename: Giselle A
authors.initials: GA
authors.lastname: Baquero
authors.forename: Jerry
authors.initials: J
authors.lastname: Luck
authors.forename: Gerald V
authors.initials: GV
authors.lastname: Naccarelli
authors.forename: Mario D
authors.initials: MD
authors.lastname: Gonzalez
authors.forename: Javier E
authors.initials: JE
authors.lastname: Banchs
mesh_terms: D058406:Cardiac Resynchronization Therapy / Q000009:adverse effects*; D017147:Defibrillators, Implantable / Q000009:adverse effects*; D006801:Humans; D010138:Pacemaker, Artificial / Q000009:adverse effects*; D014262:Tricuspid Valve Insufficiency / Q000209:etiology*